Assyro AI

FDA Orange Book · active-ingredient family

Desogestrel; ethinyl estradiol

Desogestrel; ethinyl estradiol is approved as 4 brand and 23 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:CYCLESSA · NDA 021090

4

Brand (NDA)

23

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
CYCLESSARLDASPEN GLOBAL INCNDA 021090ABDec 20, 2000
MIRCETTERLDTEVA BRANDED PHARMNDA 020713Apr 22, 1998
ORTHO-CEPTRLD×2JANSSEN PHARMSNDA 020301Dec 14, 1992
DESOGEN×2ORGANON USA INCNDA 020071Dec 10, 1992

Generic (ANDA) products (23)

ProductApplicantApplicationTEApproved
DESOGESTREL AND ETHINYL ESTRADIOLANNORA PHARMAANDA 219761ABMar 18, 2026
AVERI×2AVION PHARMSANDA 218933May 02, 2025
DESOGESTREL AND ETHINYL ESTRADIOLNAARI PTEANDA 207067ABSep 13, 2018
DESOGESTREL AND ETHINYL ESTRADIOLNAARI PTEANDA 209170ABJun 05, 2017
KALLIGAAUROBINDO PHARMAANDA 207081ABMay 17, 2017
SIMLIYAAUROBINDO PHARMAANDA 206853ABMar 22, 2017
VOLNEAXIROMEDANDA 202689ABSep 09, 2016
BEKYREELUPINANDA 202226ABAug 12, 2015
ISIBLOOMXIROMEDANDA 202789ABAug 12, 2015
DESOGESTREL AND ETHINYL ESTRADIOLXIROMEDANDA 202085May 20, 2015
KIMIDESSPH HEALTHANDA 076681Apr 30, 2015
DESOGESTREL AND ETHINYL ESTRADIOLXIROMEDANDA 202296ABAug 30, 2013
PIMTREANOVAST LABSANDA 091247ABAug 01, 2013
DESOGESTREL AND ETHINYL ESTRADIOLNOVAST LABSANDA 091234ABJul 12, 2013
ENSKYCELUPIN LTDANDA 201887ABMar 07, 2013
VIORELEGLENMARK PHARMS LTDANDA 091346ABApr 02, 2012
EMOQUETTEPH HEALTHANDA 076675Feb 25, 2011
DESOGESTREL AND ETHINYL ESTRADIOLDR REDDYS LABS SAANDA 076916Dec 29, 2008
DESOGESTREL AND ETHINYL ESTRADIOLDR REDDYS LABS SAANDA 077182Jan 24, 2006
DESOGESTREL AND ETHINYL ESTRADIOLWATSON LABSANDA 076915ABJul 29, 2005
VELIVETDURAMED PHARMS BARRANDA 076455ABFeb 24, 2004
KARIVABARRANDA 075863ABApr 05, 2002
DESOGESTREL AND ETHINYL ESTRADIOL×2DURAMED PHARMS BARRANDA 075256Aug 12, 1999

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Desogestrel; ethinyl estradiol — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.